Regenerative Medicine
Page 1 • 3 itemsUnlock global regenerative medicine market insights. NovaPharmaNews delivers critical intelligence for pharma BD, investors & analysts on cell & gene therapies.
Theradaptive Receives FDA Approval for Pivotal Phase 3 Trial of OsteoAdapt SP in Spinal Fusion
Theradaptive advances OsteoAdapt SP bone regeneration therapy to pivotal Phase 3 OASIS trial for spinal fusion after FDA approval milestone.
Orca Bio's Orca-Q Receives FDA RMAT Designation for High-Risk Blood Cancers Treatment
Orca Bio's Orca-Q therapy gains FDA RMAT designation for high-risk hematologic malignancies based on promising Phase 1 survival and safety data.
UCB Acquires Neurona Therapeutics for NRTX-1001 Epilepsy Cell Therapy in $XXX Million Deal
UCB announces acquisition of Neurona Therapeutics and lead epilepsy cell therapy NRTX-1001, currently in Phase I/II trials for treatment-resistant epilepsy patients.